English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 859705 線上人數 : 774
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
生技與藥物研究所
郭靜娟
--會議論文/會議摘要
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
生技與藥物研究所
>
郭靜娟
>
會議論文/會議摘要
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
資料載入中.....
鄰近類別
期刊論文
[
42
/42]
類別統計
近3年內發表的文件:0(0.00%)
含全文筆數:7(53.85%)
文件下載次數統計
下載大於0次:7(100.00%)
下載大於100次:7(100.00%)
檔案下載總次數:4166(18.23%)
最後更新時間: 2024-11-28 15:55
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
A novel mechanism of miRNA-mediated...
Use of integrated genomic analyses ...
Blockage of EGFR signaling repurpos...
4-Bromophenylhydrazinyl benzenesulf...
Clinical candidate DBPR112: A novel...
Establishment and characterization ...
Optimization of furanopyrimidine-ba...
Phenyl benzenesulfonylhydrazides: S...
High expression of Hsp90-beta and G...
Enhanced antitumor activity of rapa...
跳至:
(選擇年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-13 / 13. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2019-07
Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 4626.
2019-05
A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e17534.
2018-12
Establishment and characterization of novel syngeneic oral squamous cell carcinoma mouse cell lines
Cancer Science. 2018 Dec;109(Suppl. 2):386.
2018-07
Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 3944.
2018-07
4-Bromophenylhydrazinyl benzenesulfonylphenylureas inhibit indoleamine 2,3-dioxygenase in vitro and in vivo
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 1664.
2018-07
Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 4789.
2016-12
Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy
European Journal of Cancer. 2016 Dec;68(Suppl. 1):S83-S84.
2015-08
Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma
Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 180.
2015-05
Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595.
2014-11
Cytokine induces MIR-424 expression and modulates SOCS2/STAT5 signaling pathway in oral cancer
European Journal of Cancer. 2014 Nov;50(Suppl. 6):147.
2014-11
Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent
European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
2014-10
Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753.
2014-05
High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.
顯示項目1-13 / 13. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋